We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$277B
AUM Growth
+$17B
Cap. Flow
+$10.3B
Cap. Flow %
3.74%
Top 10 Hldgs %
13%
Holding
7,048
New
169
Increased
3,077
Reduced
2,915
Closed
401

Sector Composition

Rank Sector Weight
1 Healthcare 8.93%
2 Technology 8.69%
3 Financials 8.37%
4 Communication Services 6.94%
5 Consumer Staples 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCKT icon
5226
Rocket Pharmaceuticals
RCKT
$340M
$81K ﹤0.01%
2,719
-17,194
-86% -$605K
RGLS
5227
DELISTED
Regulus Therapeutics
RGLS
$81K ﹤0.01%
233
-23
-9% -$16.5K
SID icon
5228
Companhia Siderúrgica Nacional
SID
$1.31B
$81K ﹤0.01%
32,897
-131,261
-80% -$339K
FCSC
5229
DELISTED
Fibrocell Science Inc.
FCSC
$81K ﹤0.01%
4,717
+547
+13% +$17K
GSC
5230
DELISTED
GS Connect S&P GSCI Enhanced Commodity Total Return Strategy Index ETN (maturity subject to postpone
GSC
$81K ﹤0.01%
3,592
-2,133
-37% -$46.7K
BBW icon
5231
Build-A-Bear
BBW
$425M
$80K ﹤0.01%
6,000
-46,669
-89% -$624K
CRBP icon
5232
Corbus Pharmaceuticals
CRBP
$166M
$80K ﹤0.01%
887
+710
+401% +$55.7K
BQH
5233
DELISTED
BlackRock New York Municipal Bond Trust
BQH
$80K ﹤0.01%
4,974
-705
-12% -$11K
BYBK
5234
DELISTED
Bay Bancorp, Inc.
BYBK
$80K ﹤0.01%
15,797
-3,022
-16% -$15.3K
YCB
5235
DELISTED
YOUR CMNTY BANKSHARES INC COM
YCB
$80K ﹤0.01%
2,143
-2,441
-53% -$87.2K
IPS
5236
DELISTED
SPDR S&P International Consumer Staples Sector
IPS
$80K ﹤0.01%
1,824
-187
-9% -$8.04K
ARDX icon
5237
Ardelyx
ARDX
$1.22B
$79K ﹤0.01%
9,129
-33,641
-79% -$275K
AXGN icon
5238
Axogen
AXGN
$2.27B
$79K ﹤0.01%
11,522
-11,991
-51% -$67.8K
ALPN
5239
DELISTED
Alpine Immune Sciences Inc
ALPN
$79K ﹤0.01%
4,323
-2,827
-40% -$50.2K
FNCL icon
5240
Fidelity MSCI Financials Index ETF
FNCL
$2.38B
$78K ﹤0.01%
2,822
-41,492
-94% -$1.15M
NBHC icon
5241
National Bank Holdings
NBHC
$1.92B
$78K ﹤0.01%
3,787
+1,958
+107% +$39.9K
NZAC icon
5242
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$192M
$78K ﹤0.01%
4,396
+272
+7% +$4.83K
SOHO
5243
DELISTED
Sotherly Hotels
SOHO
$78K ﹤0.01%
13,750
TAYD icon
5244
Taylor Devices
TAYD
$165M
$78K ﹤0.01%
4,400
+2,695
+158% +$44K
FAV
5245
DELISTED
FIRST TRUST DIVIDEND AND INCOME FD COM
FAV
$78K ﹤0.01%
8,631
-837
-9% -$7.35K
PTX
5246
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$78K ﹤0.01%
17,559
-508,270
-97% -$3.32M
ALD
5247
DELISTED
WisdomTree Asia Local Debt Fund
ALD
$78K ﹤0.01%
1,721
+656
+62% +$29.3K
BANX
5248
ArrowMark Financial
BANX
$198M
$77K ﹤0.01%
4,200
+1,513
+56% +$26.4K
FUNC icon
5249
First United
FUNC
$285M
$77K ﹤0.01%
7,750
-2,955
-28% -$31.5K
WVVI icon
5250
Willamette Valley Vineyards
WVVI
$12.7M
$77K ﹤0.01%
9,123
-972
-10% -$7.21K

Similar funds

Morgan Stanley's Q2 2016 Portfolio in Review

As of Q2 2016, Morgan Stanley held 7,048 positions worth $277B, up 6.5% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Morgan Stanley deployed $10.3B of net new capital in Q2 2016, opening 169 new positions and adding to 3,077 existing holdings. Its largest new stake was S&P Global: 9,342,671 shares worth $1B.

By sector, the portfolio is most concentrated in Healthcare at 8.9% of assets, down from 9.1% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $542M trimmed.

  • Morgan Stanley's largest Q2 2016 buy was S&P Global: 9,342,671 shares worth $1B.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $1.11B increase.
  • Morgan Stanley's biggest Q2 2016 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $542M.
  • Morgan Stanley fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $807M.
  • Morgan Stanley's ten largest holdings make up 13% of its $277B portfolio in Q2 2016.
  • Morgan Stanley opened 169 new positions and closed 401 in Q2 2016.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $277B.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.